TITLE

Ampligen & Chronic Fatigue

AUTHOR(S)
Klotter, Jule
PUB. DATE
August 2005
SOURCE
Townsend Letter for Doctors & Patients;Aug/Sep2005, Issue 265/266, p24
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Explains that Hemispherx Biopharma, Inc. has completed a Phase III Chronic Fatigue Syndrome (CFS) trial of Ampligen, a double-stranded RNAdrug. Modulation of the immune system; Antiviral agent; Randomized, double-blind, placebo-controlled, crossover study of 234 subjects; Treadmill exercise performance.
ACCESSION #
18002543

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics